Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|November 29, 2023
Validating blood tests as a possible routine diagnostic assay of Alzheimer's diseaseEleftheria Kodosaki, Henrik Zetterberg, Amanda HeslegraveMolecular Diagnosis & Therapy|June 7, 2025
Current Methods in Clinical Alzheimer's Disease Research and DiagnosisEleftheria Kodosaki, Henrik Zetterberg, Amanda HeslegraveFrontiers in Neuroscience|November 15, 2024
More than microglia: myeloid cells and biomarkers in neurodegenerationEleftheria Kodosaki, Rosie Bell, Aitana Sogorb-Esteve, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Aging-related matrix metallopeptidase 10 and osteopontin levels are associated with pathology, cognitive decline, and age at onset in Alzheimer's diseaseBryan Ng, Eleftheria Kodosaki, Elena Veleva, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2022
Complement dysregulation and Alzheimer's disease in Down syndromeAurora Veteleanu, Sarah Pape, Kate Davies, et al.Journal of Neuroinflammation|February 17, 2024
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomesEleftheria Kodosaki, W John Watkins, Sam Loveless, et al.Brain : a Journal of Neurology|September 26, 2024
High-dimensional proteomic analysis for pathophysiological classification of traumatic brain injuryLucia M Li, Eleftheria Kodosaki, Amanda Heslegrave, et al.Brain, Behavior, & Immunity - Health|February 2, 2026
Systemic inflammation and its associations in acute moderate-severe Traumatic Brain Injury: a cross-sectional studyLucia M Li, Eleftheria Kodosaki, Chloe J Y Xu, et al.Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.Brain, Behavior, and Immunity|March 31, 2024
Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studiesJonah F Byrne, Colm Healy, Melanie Föcking, et al.Pageof 2